- Notification that Form 20-F will be submitted late (NT 20-F)
02 July 2011 - 7:12AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
|
|
|
(Check One):
|
|
¨
Form
10-K
x
Form 20-F
¨
Form 11-K
¨
Form 10-Q
¨
Form 10-D
¨
Form N-SAR
¨
Form N-CSR
|
|
|
For Period
Ended:
December 31, 2010
|
|
|
|
|
¨
Transition Report on Form 10-K
|
|
¨
Transition Report on Form 10-Q
|
¨
Transition Report on Form 20-F
¨
Transition Report on Form 11-K
|
|
¨
Transition Report on Form N-SAR
|
|
For the Transition Period Ended:
|
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I
REGISTRANT INFORMATION
CDC Corporation
Full name of registrant
N/A
Former
name if applicable
11/F ING Tower
308 Des Voeux Road
Address of principal executive office (
Street and
number
)
Central Hong Kong
City, state and zip code
001-30134
Commission File Number
G2022L 11 4
CUSIP Number
1
PART II
RULES 12b-25 (b) AND (c)
If the subject report could not be filed without
unreasonable effort or expense and the registrant seeks relief pursuant to
Rule 12b-25(b), the following should be completed. (Check box
if appropriate.)
|
|
|
|
|
x
|
|
(a)
|
|
The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable
effort or expense
|
|
(b)
|
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or
Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
|
|
(c)
|
|
The accountants statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART III
NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR,
N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
In connection with the preparation
of its consolidated financial statements for the fiscal year ended December 31, 2010 (the Financial Statements), CDC Corporation (the Company) encountered difficulties in completing the accounting of, and reporting for,
certain matters, and preparing related disclosures. As a result, the Company cannot, without unreasonable expense and effort, complete the Financial Statements in sufficient time to permit the filing of its Annual Report on Form 20-F for the fiscal
year ended December 31, 2010 (the Form 20-F). The Companys management is evaluating matters related to the Financial Statements, including the analysis of the Companys short term cash needs in relation to existing
litigation, the application of US GAAP to certain transactions, the impact of litigation, and the impairment of certain intangibles. Management also anticipates recording impairment charges as a result of this analysis, and is evaluating the
impact of these issues on the Companys access to capital and available liquidity.
The Company plans to file the Form 20-F as soon as
practicable after the completion of the Audit Committees review, the completion of any additional accounting work required as a result of such review and the finalization of the Financial Statements and associated disclosures. The Company
intends to file the Form 20-F on or before the fifteenth calendar day following its prescribed due date, as required by Rule 12b-25.
PART IV
OTHER INFORMATION
|
(1)
|
Name and telephone number of person to contact in regard to this notification:
|
Donald L. Novajosky, Vice President, Associate General Counsel & Secretary
678-259-8669
|
(2)
|
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940
during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
|
x
Yes
¨
No
|
(3)
|
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
|
¨
Yes
x
No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
2
This Form 12b-25 contains statements, including statements regarding the internal review currently being
undertaken by the Company, statements as to the Companys projected filing of the Form 20-F, and statements regarding the precise impact on the financial statements or the Company, if one is required, that are forward-looking
statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements reflect the Companys currently expectations, but the Company can give no assurance that such expectations will prove to be accurate. The
Companys expectations in these forward-looking statements may prove to be incorrect. Actual results could vary materially from the description contained herein due to many factors, including the outcome of the Companys internal review,
including a determination that the matters under internal review were more widespread than originally contemplated or that other accounting errors have been made historically, which could require adjustments to the Companys estimates. The
Company can also make no assurance that, as a result of its internal review, additional accounting issues will not be uncovered that will have an impact on past or future results of operations. The forward-looking statements made in this Form 12b-25
speak only as of today and the Company does not undertake any obligation to update any such statements to reflect events or circumstances occurring after today.
3
CDC Corporation
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
Date: July 1, 2011
|
|
By:
|
|
/s/ John A. Stone
|
|
|
|
|
|
Name:
|
|
John A. Stone
|
|
|
|
|
|
Title:
|
|
Chief Financial Officer
|
4
Cdc Corp. (MM) (NASDAQ:CHINA)
Historical Stock Chart
From May 2024 to Jun 2024
Cdc Corp. (MM) (NASDAQ:CHINA)
Historical Stock Chart
From Jun 2023 to Jun 2024